Effect of gastric bypass on BMI and lipid metabolism in type 2 diabetes mellitus

References

• Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–256.
   PubMed Web of Science ®Google Scholar
• Li W, Zhu L, Mo Z, et al. Effect of laparoscopic Roux-en-Y gastric bypass on body composition and insulin resistance in Chinese patients with type 2 diabetes mellitus. Obes Surg. 2014;24(4):578–583.
   PubMed Web of Science ®Google Scholar
• Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 2017;23(7):804–814.
   PubMed Web of Science ®Google Scholar
• Kansou G, Lechaux D, Delarue J, et al. Laparoscopic sleeve gastrectomy versus laparoscopic mini gastric bypass: one year outcomes. Int J Surg. 2016;33:18–22.
   PubMed Web of Science ®Google Scholar
• Benaiges D, Flores Le-Roux JA, Pedro-Botet J, et al. Sleeve gastrectomy and Roux-en-Y gastric bypass are equally effective in correcting insulin resistance. Int J Surg. 2013;11(4):309–313.
   PubMed Web of Science ®Google Scholar
• Dodd GT, Decherf S, Loh K, et al. Leptin and insulin act on POMC neurons to promote the browning of white fat. Cell. 2015;160(1–2):88–104.
   PubMed Web of Science ®Google Scholar
• Geloneze B, Geloneze SR, Chaim E, et al. Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study. Ann Surg. 2012;256(1):72–78.
   PubMed Web of Science ®Google Scholar
• Navarrete SA, Leyba JL, Llopis SN. Laparoscopic sleeve gastrectomy with duodenojejunal bypass for the treatment of type 2 diabetes in non-obese patients: technique and preliminary results. Obes Surg. 2011;21(5):663–667.
   PubMed Web of Science ®Google Scholar
• Baskota A, Li S, Dhakal N, et al. Bariatric surgery for type 2 diabetes mellitus in patients with BMI <30 kg/m2: a systematic review and meta-analysis. PLoS One. 2015;10(7):e0132335.
   PubMed Web of Science ®Google Scholar
• Reis CE, Alvarez-Leite JI, Bressan J, et al. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14(4):365–372.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–959.
   PubMed Web of Science ®Google Scholar
• Liu JG, Zheng CZ, Wang Y. Guidelines for surgical treatment of obesity and type 2 diabetes in China. Chin J Pract Surg. 2014;34(11):1005–1010.
   Google Scholar
• Zhang Y, Zhao H, Cao Z, et al. A randomized clinical trial of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity in China: a 5-year outcome. Obes Surg. 2014;24(10):1617–1624.
   PubMed Web of Science ®Google Scholar
• Shu C, Shangping D, Tong W, et al. Normal serum leptin and its relationship with type 2 diabetes in Chengdu, China. Chin J Endocrinol Metabol. 2000;3:57.
   Google Scholar
• Hongyan W, Zhusen L, Dajin Z. Analysis of serum adiponectin level in normal people. J Naval Gen Hospital. 2005;1:29–32.
   Google Scholar
• Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–2135.
   PubMed Web of Science ®Google Scholar
• Cui H, López M, Rahmouni K. The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol. 2017;13(6):338–351.
   PubMed Web of Science ®Google Scholar
• Haffner SM, Stern MP, Hazuda HP, et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263(21):2893–2898.
   PubMed Web of Science ®Google Scholar
• Farooqi IS, O’Rahilly S. 20 years of leptin: human disorders of leptin action. J Endocrinol. 2014;223(1):T63–T70.
   PubMed Web of Science ®Google Scholar
• Engin A. Adiponectin-resistance in obesity. Adv Exp Med Biol. 2017;960:415–441.
   PubMed Web of Science ®Google Scholar
• Shoar S, Saber AA. Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies. Surg Obes Relat Dis. 2017;13(2):170–180.
   PubMed Web of Science ®Google Scholar
• Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord. 1998;22(12):1164–1171.
   PubMed Web of Science ®Google Scholar
• Ko GT, Tang JS. Waist circumference and BMI cut-off based on 10-year cardiovascular risk: evidence for “central pre-obesity”. Obesity. 2007;15(11):2832–2839.
   PubMed Web of Science ®Google Scholar
• Cummings DE, Cohen RV. Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery. Lancet Diabetes Endocrinol. 2014;2(2):175–181.
   PubMed Web of Science ®Google Scholar
• Lee WJ, Almulaifi A, Chong K. The effect and predictive score of gastric bypass and sleeve gastrectomy on type 2 diabetes mellitus patients with BMI < 30 kg/m(2). Obes Surg. 2015;25(10):1772–1778.
   PubMed Web of Science ®Google Scholar
• Kim JW, Cheong JH, Hyung WJ, et al. Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol. 2012;18(1):49–54.
   PubMed Web of Science ®Google Scholar
• Aguilar D, Fernandez ML. Hypercholesterolemia induces adipose dysfunction in conditions of obesity and nonobesity. Adv Nutr. 2014;5(5):497–502.
   PubMed Web of Science ®Google Scholar
• Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology. 2015;149(2):379–388.
   PubMed Web of Science ®Google Scholar
• Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–1576.
   PubMed Web of Science ®Google Scholar